The global biologics market is currently undergoing a seismic shift. Unlike traditional small-molecule drugs, biologics—including monoclonal antibodies (mAbs), vaccines, and recombinant proteins—are derived from living organisms. Today, they represent over 30% of the total pharmaceutical market value. From North America to the emerging markets in Asia-Pacific, the demand for high-quality biologics has skyrocketed due to the rising prevalence of chronic diseases and the breakthrough success of mRNA technologies.
Modern industrialization of biologics requires extreme precision. The trend is moving toward Single-Use Technologies (SUT) and modular manufacturing facilities. These innovations allow companies to switch between different product lines rapidly, reducing the risk of cross-contamination and shortening the time-to-market. For global enterprises, the focus is now on decentralized manufacturing—setting up localized production hubs to ensure supply chain resilience.
Check out our advanced Marya Advanced Aseptic RTU Filling Machine for efficient biologics manufacturing.
As a leading China Top Biologics Drugs Manufacturer and Supplier, Hangzhou Jeci Biochem Technology Co., Ltd. leverages the unique strengths of the Chinese industrial ecosystem. We provide a bridge between cutting-edge technology and cost-effective production.
Our Biologics Liquid Preparation System exemplifies the turnkey efficiency we offer to our international partners.
In China, we have a strong collaborative R&D team, working in depth with new drug research institutes and multiple custom processing plants. We have very good domestic sales channels and have long-term relationships with domestic companies, including product applications, technology transfer, product supply, custom processing, and exclusive agents for multiple products in multiple regions. In addition, we also provide factory quality management system certification consulting services.
Internationally, we have long-term trade relations with India, Southeast Asia, South Korea, Japan and other markets, and provides products in the whole process of market and sales services. At the same time, we also provide product registration, consulting and sales channel expansion services for overseas companies in the Chinese market.
Our drugs and intermediates are widely used across the biotech spectrum:
We are able to assemble and produce larger quantities of intermediates and provide some advanced, convenient manufacturing capabilities, including batch processing and customization. For the company's main product intermediates: We can maximize our advantages, meet the requirements of most customers and complete the task within the specified time limit.
SJ medical
